Brian Daniels
InvestorPartner at 5AM Ventures
San Francisco Bay Area
Writes $100K β $5M checks Β· typically $1.5M
FoundedCabaletta BioRarecyte
Experience
- 5AM VenturesVenture Partnercurrent2025 β present
- 5AM VenturesPartner2018 β 2025
- 5AM VenturesVenture Partner2014 β 2018
- CSLBoard Membercurrent2024 β present
- Artiva BiotherapeuticsBoard Membercurrent2021 β present
- Novo NordiskBoard Member2016 β 2021
- The Boston Consulting GroupSenior Advisor2015 β 2018
- Bristol-Myers SquibbSenior Vice President (retired), Global Development and Medical Affairs2004 β 2014
- Bristol-Myers SquibbVice President, Immunology2000 β 2004
- MerckDirector, Immunology1996 β 2000
Education
- Washington University in St. LouisDoctor of Medicine (MD)1983 β 1987
- Massachusetts Institute of TechnologyM.S., Biology1980 β 1981
- Massachusetts Institute of TechnologyBS, Biology/Biological Sciences1977 β 1981
Skills & more
Immunology62Pharmaceutical Industry51Clinical Development44Medical Affairs28Translational Medicine7Clinical Trials27Biotechnology38Drug Development19CRO21Drug Discovery8Life Sciences13Oncology21
+6 more
Infectious DiseasesRegulatory AffairsBiopharmaceuticalsGCPRegulatory SubmissionsLifesciencesFrom Brian's professional profile.
Same school
Also attended Washington University in St. Louis144
Lee FixelFounder of AdditionMax WechterSenior Director of AI at Lerer HippeauMark LevinRetired Founding Partner at Third Rock VenturesMitzi KrockoverInvestor at Golden SeedsMara BabinInvestor at Golden SeedsAndrea JacksonPartner at Northpond Ventures
+ 138 more
Also attended Massachusetts Institute of Technology977
Fred WilsonCo-founder & Partner at Union Square VenturesAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsMatt HuangCo-founder and Managing Partner at ParadigmDelian AsparouhovPartner at Founders Fund and co-founder of Varda
+ 971 more
Shared employers
Also worked at CSL4
Also worked at Artiva Biotherapeutics1
Also worked at Novo Nordisk17
Jesper GromadaInvestor at Third Rock VenturesEmilia CarlqvistAnalyst, Innovestor Life Science at Innovestor VenturesDhiren PatelDigital Pharma Advisor at Excelerate Health VenturesTaruho KurodaImpact Partner at Fresco CapitalThomas NagyOperational Partner at Astanor VenturesHenrijette RichterManaging Partner at Sofinnova Partners
+ 11 more
Also worked at The Boston Consulting Group730
David SzeAdvisory Partner at GreylockDave MunichielloInvestor at GV (Google Ventures)Massimo PrelzInvestor at DN CapitalRasmus AreskougInvestor at DN CapitalRiccardo MontiOperating Advisor at P101 VenturesAntonio TurroniOperating Advisor at P101 Ventures
+ 724 more
Deals Β· 2
Cabaletta BioBoard seat
via 5AM Ventures Β· filed Dec 2018
Ideaya BiosciencesBoard seat
via 5AM Ventures Β· filed May 2018 Β· $94M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at 5AM Ventures
Alex Wareham
Management Company Controller at 5AM Ventures
Andy Schwab
Managing Partner at 5AM Ventures
Aniqa Tasnim
Senior Associate at 5AM Ventures
Anna Yaeger
Chief Investment Officer and Partner at 5AM Ventures
Arthur Tzianabos
Venture Partner at 5AM Ventures
Bella Nittolo
Administrative Assistant and Office Manager at 5AM Ventures
Britt Inga Emerson
Associate Director, Investor Relations at 5AM Ventures
Caroline Chamales
Senior Executive Assistant at 5AM Ventures
Network5
Andy Schwab
Managing Partner at 5AM Ventures
Deborah Palestrant
Partner, Executive Chair, 4:59 Initiative at 5AM Ventures
Jamil Beg
Partner at 5AM Ventures
John Diekman
Founding Partner at 5AM Ventures
Katie Bodner Spielberg
Principal at 5AM Ventures
Investors connected to Brian in public investor directories β a warm-intro map.



































